Ultrasound Workspace (UWS 6.0) vs EchoGo Amyloidosis
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A is a comprehensive, AI-powered platform designed to streamline general echocardiography workflows, offering automated measurements and vendor-neutral analysis for various cardiovascular conditions. In contrast, Tool B is a specialized AI screening tool focused solely on aiding in the early detection of cardiac amyloidosis from echocardiogram video clips. While both operate in Cardiology AI, Tool A serves as a broad workflow solution, whereas Tool B provides a targeted diagnostic aid for a specific disease.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Philips Ultrasound Workspace (UWS 6.0) is a comprehensive system for general cardiovascular viewing, analysis, and reporting, designed to streamline echocardiography workflows. Ultromics' EchoGo Amyloidosis is an AI-powered screening tool specifically for the early detection of cardiac amyloidosis from echocardiogram video clips.
UWS 6.0 offers AI-powered automated measurements for various cardiac structures and functions, such as Auto Measure and AutoStrain LV. EchoGo Amyloidosis uses AI to analyze echocardiogram video clips to identify suspected cardiac amyloidosis, providing a diagnostic output of 'suggestive' or 'not suggestive' of the condition.
Philips Ultrasound Workspace (UWS 6.0) explicitly states that it offers vendor-neutral and multi-vendor data analysis for standardization. Ultromics' EchoGo Amyloidosis is also described as vendor-neutral, connecting with any system.
For Philips Ultrasound Workspace (UWS 6.0), pricing requires contacting a Philips representative. For Ultromics' EchoGo Amyloidosis, specific reimbursement details are provided, including NTAP Code ICD-10 XXE2X19 for inpatient analysis and HCPCS Code C9786 for outpatient analysis, covered by Medicare and select commercial insurers.
UWS 6.0 provides comprehensive cardiovascular software solutions for review, image analysis, and reporting, including AI-powered automated measurements. EchoGo Amyloidosis delivers a diagnostic output of 'suggestive' or 'not suggestive' of cardiac amyloidosis based on its AI analysis of echocardiographic markers.